These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 32089472)
1. Has Stage Migration in Renal Cancer Run Its Course? A SEER Database Analysis. Haifler M; Neheman A; Zisman A Clin Genitourin Cancer; 2020 Aug; 18(4):e368-e373. PubMed ID: 32089472 [TBL] [Abstract][Full Text] [Related]
2. Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma. Ma Z; Yi Y; Qiu Z Fr J Urol; 2024 Mar; 34(2):102573. PubMed ID: 38330829 [TBL] [Abstract][Full Text] [Related]
3. Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study. Saad AM; Gad MM; Al-Husseini MJ; Ruhban IA; Sonbol MB; Ho TH Clin Genitourin Cancer; 2019 Feb; 17(1):46-57.e5. PubMed ID: 30391138 [TBL] [Abstract][Full Text] [Related]
4. Rising incidence of small renal masses: a need to reassess treatment effect. Hollingsworth JM; Miller DC; Daignault S; Hollenbeck BK J Natl Cancer Inst; 2006 Sep; 98(18):1331-4. PubMed ID: 16985252 [TBL] [Abstract][Full Text] [Related]
5. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. King SC; Pollack LA; Li J; King JB; Master VA J Urol; 2014 Jun; 191(6):1665-70. PubMed ID: 24423441 [TBL] [Abstract][Full Text] [Related]
6. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Sun M; Thuret R; Abdollah F; Lughezzani G; Schmitges J; Tian Z; Shariat SF; Montorsi F; Patard JJ; Perrotte P; Karakiewicz PI Eur Urol; 2011 Jan; 59(1):135-41. PubMed ID: 21035250 [TBL] [Abstract][Full Text] [Related]
7. Racial disparity in incidence patterns and outcome of kidney cancer. Vaishampayan UN; Do H; Hussain M; Schwartz K Urology; 2003 Dec; 62(6):1012-7. PubMed ID: 14665346 [TBL] [Abstract][Full Text] [Related]
8. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. Hock LM; Lynch J; Balaji KC J Urol; 2002 Jan; 167(1):57-60. PubMed ID: 11743275 [TBL] [Abstract][Full Text] [Related]
9. Rising incidence of renal cell cancer in the United States. Chow WH; Devesa SS; Warren JL; Fraumeni JF JAMA; 1999 May; 281(17):1628-31. PubMed ID: 10235157 [TBL] [Abstract][Full Text] [Related]
10. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. Scoll BJ; Wong YN; Egleston BL; Kunkle DA; Saad IR; Uzzo RG J Urol; 2009 Feb; 181(2):506-11. PubMed ID: 19084868 [TBL] [Abstract][Full Text] [Related]
11. Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis. He H; Chen N; Hou Y; Wang Z; Zhang Y; Zhang G; Fu J Thorac Cancer; 2020 May; 11(5):1121-1128. PubMed ID: 32154652 [TBL] [Abstract][Full Text] [Related]
12. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4). Milano AF J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210 [TBL] [Abstract][Full Text] [Related]
13. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017. Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230 [TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
15. Trends analysis of cancer incidence, mortality, and survival for the elderly in the United States, 1975-2020. Xu J; Liao J; Yan Q; Jiao J; Hu N; Zhang W; Shi L; Deng M; Huang S; Tang X Cancer Med; 2024 Aug; 13(15):e70062. PubMed ID: 39082934 [TBL] [Abstract][Full Text] [Related]
16. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma. Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864 [TBL] [Abstract][Full Text] [Related]
17. Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States. Patel HD; Gupta M; Joice GA; Srivastava A; Alam R; Allaf ME; Pierorazio PM Eur Urol Oncol; 2019 Jul; 2(4):343-348. PubMed ID: 31277771 [TBL] [Abstract][Full Text] [Related]
18. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. Lim H; Devesa SS; Sosa JA; Check D; Kitahara CM JAMA; 2017 Apr; 317(13):1338-1348. PubMed ID: 28362912 [TBL] [Abstract][Full Text] [Related]
19. Impact of gender in renal cell carcinoma: an analysis of the SEER database. Aron M; Nguyen MM; Stein RJ; Gill IS Eur Urol; 2008 Jul; 54(1):133-40. PubMed ID: 18160207 [TBL] [Abstract][Full Text] [Related]
20. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Abdollah F; Gandaglia G; Thuret R; Schmitges J; Tian Z; Jeldres C; Passoni NM; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M Cancer Epidemiol; 2013 Jun; 37(3):219-25. PubMed ID: 23485480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]